| Tue, Nov 24, 2009 |
| • |
4 Platform Drugmakers to Invest In
at Motley Fool (Tue 3:20pm)
|
| Fri, Nov 20, 2009 |
| • |
UPDATE - HealthCor slams Biogen CEO for outsize pay package
at Reuters (Fri, Nov 20)
|
| Thu, Nov 12, 2009 |
| • |
Thursday Options Recap
at Seeking Alpha (Thu, Nov 12)
|
| Wed, Nov 11, 2009 |
| • |
When Rival Drug Makers Compare Notes On Safety Problems
at The Wall Street Journal Online (Wed, Nov 11)
|
| • |
Cramer's Lightning Round - The Only Water Stock Worth Buying (11/10/09)
at Seeking Alpha (Wed, Nov 11)
|
| Tue, Nov 10, 2009 |
| • |
Lightning Round: Priceline.com, Citigroup, Transocean and More
at CNBC (Tue, Nov 10)
|
| • |
Elan to Present at Lazard Capital Markets 6th Annual Healthcare Conference
Business Wire (Tue, Nov 10)
|
| Mon, Nov 9, 2009 |
| • |
Successful Pharmaceutical Company Mergers: Abbott Labs Is Leader
Wall Street Transcript (Mon, Nov 9)
|
| • |
A Bear in the Bullpen: 3 Power Ratings Stocks Ready to Drop
TradingMarkets.com (Mon, Nov 9)
|
| Sat, Nov 7, 2009 |
| • |
Elan, Biogen change Tysabri label due to PML risk
at Reuters (Sat, Nov 7)
|
| Tue, Nov 3, 2009 |
| • |
Nice Quarter, Teva. What Will You Buy Next?
at Motley Fool (Tue, Nov 3)
|
| • |
UPDATE - J&J slashing workforce, cites cost of drug research
at Reuters (Tue, Nov 3)
|
| • |
Buffett to buy Burlington Northern in his biggest deal ever
Reuters (Tue, Nov 3)
|
| • |
Johnson & Johnson to cut up to 8,200 jobs
at MarketWatch (Tue, Nov 3)
|
| Fri, Oct 30, 2009 |
| • |
Healthcare Earnings Are Coming Into Focus
at Investopedia (Fri, Oct 30)
|
| Thu, Oct 29, 2009 |
| • |
Hydro-Quebec sees U.S. growth via NB Power assets
Reuters (Thu, Oct 29)
|
| • |
Elan Corporation Plc Announces Expiration of Tender Offer for 7¾% Senior Fixed Rate Notes Due 2011
Business Wire (Thu, Oct 29)
|
| • |
3 Stocks in a Tailspin
at Motley Fool (Thu, Oct 29)
|
| • |
UPDATE - EU agency reports 24th case of Tysabri infection
at Reuters (Thu, Oct 29)
|
| • |
5-Star Stocks Poised to Pop: MEMC
at Motley Fool (Thu, Oct 29)
|
| Older Headlines |
|
|
|
|
Help
0.005 (0.08%) 
Headlines
